Surgical sealants and tissue patches market seen reaching $4.08 billion by 2030

The surgical sealants and tissue patches market is projected to grow from $2.56 billion in 2025 to $4.08 billion by 2030, driven by more surgeries, rising trauma cases and wider use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Surgical sealants and tissue patches are increasingly used to manage bleeding, seal tissue and support wound healing during surgery. - Growth in this market tracks broader demand for products that can reduce complications, shorten recovery times and replace or supplement traditional sutures. - Rising trauma, cardiovascular and orthopedic cases add to demand across hospitals and specialized surgical settings.

What happened: - The Business Research Company released its Surgical Sealants And Tissue Patches Market Report 2026, covering market size, trends and global forecasts for 2026-2035. - The market is projected to rise from $2.56 billion in 2025 to $2.82 billion in 2026, a 10.0% CAGR. - The market is expected to reach $4.08 billion by 2030, growing at a 9.7% CAGR over the forecast period. - North America held the largest share of the global market in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years.

The details: - Surgical sealants are bioadhesive substances that bond tissues and help prevent leakage of fluids or air. - Tissue patches provide structural support and are used to help tissue regeneration. - The products are used in cardiovascular, orthopedic and general surgeries. - Market growth is being driven by higher surgical volumes, rising cardiovascular and orthopedic conditions, greater preference for sealants over sutures and expanded hospital surgical capacity. - Other growth factors include broader use of advanced biomaterials and more investment in surgical biomaterials. - The report says demand is also being supported by more accidents and sports-related injuries. - The report cites March 2025 Australian government data showing 1,292 road fatalities in the 12 months ending February 2025, up 1.6% from the prior year. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company offers a free sample of the market report and the full market report. - The company lists updated analytical tools for the 2026 edition, including future trend analysis and key technology coverage.

Between the lines: - The forecast points to sustained demand for surgical products that support minimally invasive procedures and reduce post-operative complications. - The fastest growth in Asia-Pacific suggests surgical demand is expanding beyond mature markets, even though North America remains the largest regional market. - The emphasis on bioengineered, synthetic and hybrid products suggests innovation is becoming a key competitive factor.

What's next: - The market is expected to keep expanding as minimally invasive surgery, regenerative medicine and hemostatic technologies gain broader use. - Expanded applications in specialized surgical fields should add to future growth. - Greater adoption of advanced biomaterials may continue to reshape product development and purchasing decisions.

The bottom line: - Surgical sealants and tissue patches are moving from niche surgical aids to a broader growth market with multi-year expansion built into the forecast.